{"id":"https://openalex.org/W4392294520","doi":"https://doi.org/10.1080/14728222.2024.2326211","title":"Considerations on the implementation of MAP4K4 inhibitors as cancer treatment","display_name":"Considerations on the implementation of MAP4K4 inhibitors as cancer treatment","publication_year":2024,"publication_date":"2024-02-29","ids":{"openalex":"https://openalex.org/W4392294520","doi":"https://doi.org/10.1080/14728222.2024.2326211","pmid":"https://pubmed.ncbi.nlm.nih.gov/38421000"},"language":"en","primary_location":{"id":"doi:10.1080/14728222.2024.2326211","doi":"https://doi.org/10.1080/14728222.2024.2326211","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1080/14728222.2024.2326211","pdf_url":null,"source":{"id":"https://openalex.org/S149756942","display_name":"Expert Opinion on Therapeutic Targets","issn_l":"1472-8222","issn":["1472-8222","1744-7631"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Targets","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repositorio.uchile.cl/handle/2250/216328","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073068359","display_name":"Jaime Gonz\u00e1lez\u2010Montero","orcid":"https://orcid.org/0000-0003-0324-2948","observed_orcids":["https://orcid.org/0000-0003-0324-2948"]},"institutions":[{"id":"https://openalex.org/I69737025","display_name":"University of Chile","ror":"https://ror.org/047gc3g35","country_code":"CL","type":"education","lineage":["https://openalex.org/I69737025"]}],"countries":["CL"],"is_corresponding":false,"raw_author_name":"Jaime Gonzalez-Montero","raw_affiliation_strings":["Basic and Clinical Oncology Department, University of Chile, Santiago, Chile","Oncology Department, Bradford Hill Clinical Research Center, Santiago, Chile"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basic and Clinical Oncology Department, University of Chile, Santiago, Chile","institution_ids":["https://openalex.org/I69737025"]},{"raw_affiliation_string":"Oncology Department, Bradford Hill Clinical Research Center, Santiago, Chile","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074832020","display_name":"Mauricio Burotto","orcid":"https://orcid.org/0000-0002-7150-4033","observed_orcids":["https://orcid.org/0000-0002-7150-4033"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mauricio Burotto","raw_affiliation_strings":["Oncology Department, Bradford Hill Clinical Research Center, Santiago, Chile"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Bradford Hill Clinical Research Center, Santiago, Chile","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5074832020"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"3","first_page":"113","last_page":"115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.7505000233650208,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.7505000233650208,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.13279999792575836,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.05950000137090683,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/map4k4","display_name":"MAP4K4","score":0.9700000286102295},{"id":"https://openalex.org/keywords/serine-threonine-kinase","display_name":"serine/threonine kinase","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.8159999847412109},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.7979999780654907},{"id":"https://openalex.org/keywords/cell-migration","display_name":"cell migration","score":0.6480000019073486},{"id":"https://openalex.org/keywords/embryonic-development","display_name":"embryonic development","score":0.7850000262260437}],"concepts":[{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.4976792633533478},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49730756878852844},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4664795994758606},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3651670217514038},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3501346707344055},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26856115460395813}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/14728222.2024.2326211","doi":"https://doi.org/10.1080/14728222.2024.2326211","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1080/14728222.2024.2326211","pdf_url":null,"source":{"id":"https://openalex.org/S149756942","display_name":"Expert Opinion on Therapeutic Targets","issn_l":"1472-8222","issn":["1472-8222","1744-7631"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Targets","raw_type":"journal-article"},{"id":"pmid:38421000","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38421000","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on therapeutic targets","raw_type":"Editorial"},{"id":"pmh:oai:repositorio.uchile.cl:2250/216328","doi":null,"is_oa":true,"landing_page_url":"https://repositorio.uchile.cl/handle/2250/216328","pdf_url":null,"source":{"id":"https://openalex.org/S4306481413","display_name":"Universidad de Chile","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Opinion on Therapeutic Targets","raw_type":"Art\u00edculo de revista"}],"best_oa_location":{"id":"pmh:oai:repositorio.uchile.cl:2250/216328","doi":null,"is_oa":true,"landing_page_url":"https://repositorio.uchile.cl/handle/2250/216328","pdf_url":null,"source":{"id":"https://openalex.org/S4306481413","display_name":"Universidad de Chile","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Opinion on Therapeutic Targets","raw_type":"Art\u00edculo de revista"},"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W71660379","https://openalex.org/W1490956705","https://openalex.org/W2002731589","https://openalex.org/W2030069449","https://openalex.org/W2103665862","https://openalex.org/W2169449961","https://openalex.org/W2545902571","https://openalex.org/W2789352782","https://openalex.org/W2795218213","https://openalex.org/W2901004429","https://openalex.org/W2972456598","https://openalex.org/W2975786428","https://openalex.org/W3045412411","https://openalex.org/W3162191454","https://openalex.org/W3200783478","https://openalex.org/W4200614003","https://openalex.org/W4303685835","https://openalex.org/W4311870277","https://openalex.org/W4375864403","https://openalex.org/W4376620999","https://openalex.org/W4382344916"],"related_works":["https://openalex.org/W4375864403","https://openalex.org/W4384828345","https://openalex.org/W2545902571","https://openalex.org/W2187993602","https://openalex.org/W2604476957","https://openalex.org/W4414684062","https://openalex.org/W4311870277","https://openalex.org/W4398794712","https://openalex.org/W2003795734","https://openalex.org/W4253442511"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2024-03-05T00:00:00"}